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Abstract
Background and aim
Long standing vitamin D deficiency in children causes rickets with growth impairment. We
investigated whether sub-ischial leg length (SLL) is shorter, and cephalo-caudal length:
length (CCL:L) ratio and sitting height:height (SH:H) ratio larger, with lower cord s-25-hydro-
xyvitamin D (25OHD) in the population-based prospective Odense Child Cohort, Denmark.
Methods
We included healthy singletons born to term with available measures of cord 25OHD and
anthropometrics up to three years’ age. Linear regression was stratified by sex a priori and
adjusted for maternal ethnicity, pre-pregnancy body mass index and smoking during preg-
nancy, season of blood sampling and child age.
Results
Median (IQR) cord 25OHD was 48.0 (34.0–62.4) nmol/L. At mean age 19.1 months, n =
504, mean (SD) SLL was 31.7 (1.7) cm; CCL:L-ratio 0.62 (0.01). At 36.3 months, n = 956,
mean SLL was 42.9 (2.0) cm; SH:H-ratio 0.56 (0.01). No participants had rickets. In adjusted
analyses, 19-months-old boys had 0.1 cm shorter SLL (p = 0.009) and 0.1% higher CCL:L-
ratio (p = 0.04) with every 10 nmol/L increase in cord 25OHD. Similar findings were seen for
late pregnancy 25OHD. In the highest cord 25OHD quartile (>60.7 nmol/L), SLL was 0.8 cm
shorter (95% C.I.: 1.36;-0.29, linear trend, p = 0.004), and CCL:L-ratio 0.8% higher (95% C.
I. 8.0x10-05;0.01, linear trend, p = 0.01), compared to lowest quartile (<30.7 nmol/L). Similar
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associations with cord 25OHD were observed in 3-year-old boys. No consistent associa-
tions between 25OHD and anthropometrics were seen in girls at either age.
Conclusion
No leg shortening was found with decreasing cord s-25OHD in a healthy population of
infants. A small, yet significant inverse association between cord 25OHD and SLL in boys
1½-3 years warrants further investigations.
Introduction
Vitamin D is well known for its calciotropic effects being pivotal to bone mineralization and
linear bone growth in children. Severe vitamin D deficiency in children manifests clinically as
rickets characterized by mineralization failure of the growth plates and of the newly formed
osteoid at the bone matrix [1]. Rickets exerts a broad palette of symptoms including disturbed
apoptosis of the chondrocytes leading to cartilage hyperplasia of the growth plates in the meta-
physeal bone with widening of the growth zones at wrists, ankles and knees [2]. Furthermore,
long bone growth impairment and bowing of weight-bearing long bones may lead to dispro-
portional linear growth with shortening of the sub-ischial leg length (SLL) and thereby an
increased ratio of sitting height to height (SH:H). Hypovitaminosis D may be defined as vita-
min D deficiency or insufficiency (serum-25-hydroxyvitamin D (25OHD) < 25 nmol/L and
25–50 nmol/L, respectively) [3], although the most appropriate cut points are still under debate
[4, 5]. The existing cut-off limits are generated in terms of adult bone-health and the applica-
bility to children remains unknown [4–8]. In pregnancy, an increase in the active vitamin D
calcitriol (1,25(OH)2D) ensures calcium and phosphate supply to the foetus. In foetal life, para-
thyroid-hormone-related protein (PTHrP) is the primary regulator of the mineral homeostasis
and bone mineralization, which in the foetus is independent of maternal vitamin D and occurs
uncomplicated as long as sufficient calcium and phosphorous is supplied from the maternal
circulation across the placenta. This transport is independent of active vitamin D [9, 10].
Maternal 25OHD crosses the placenta and, as the foetus has no endogenous synthesis of
25OHD, maternal vitamin D insufficiency during pregnancy implies vitamin D insufficiency
in the new born. This leaves the infant more susceptible to developing vitamin D deficiency
rickets if not receiving adequate vitamin D supplementation, as the lower inborn vitamin D
stores will decrease to severely insufficient levels sooner in accordance with the half-life of
25OHD.
Inborn rickets due to vitamin D deficiency, however, is very rare, but may be seen in chil-
dren of mothers with severe vitamin D deficiency, osteomalacia and low s-calcium during
pregnancy [11]. Cord 25OHD levels only amount to a fraction of the levels in the maternal cir-
culation at time of delivery [12, 13], in part caused by placental production of the enzyme,
CYP24A1, responsible for the biodegradation of 25OHD and 1,25(OH)2D3 [14–16]. Low foetal
vitamin D stores may therefore further decrease to critical levels soon after birth, in the
absence of infant vitamin D supplementation.
Skeletal manifestations of vitamin D deficiency rickets rarely becomes apparent after weeks,
more often after months from birth [10]. A Danish study found vitamin D deficiency rickets
to be diagnosed between 0.3 to 3.6 years of age with a median age at diagnosis of 1.4 years [17].
Although maternal vitamin D status during pregnancy has no impact on foetal bone minerali-
sation if calcium supply is adequate, observational studies have linked low maternal vitamin D
Cord vitamin D and growth
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levels with smaller child bone mass and impaired linear growth in the first 12 months of life
[18–20]. Results are conflicting regarding linear growth in older children [21–23].
Vitamin D deficiency and insufficiency are still common in pregnancy and neonates [24].
In the Municipality of Odense, Denmark, s-25OHD <50 nmol/L was observed in 27.8% of
early pregnant women, in 15.8% of late pregnant women [25], but in 57.7% of the cord blood
samples [26]. If low maternal or cord 25OHD is linked to diminished infant growth, especially
of the long bones, despite vitamin D supplementation recommendations, an important poten-
tial for enforced prevention strategies is suggested, even in populations with low incidence of
vitamin D deficiency rickets.
On this background we aimed to investigate the relationship between early life vitamin D
exposure and linear growth in children up to three years of age in the large, Danish, popula-
tion-based Odense Child Cohort (OCC).
Methods
OCC is an on-going prospective birth cohort recruiting pregnant women residing in the
Municipality of Odense, Denmark, between January 1st 2010 and December 31st 2012 as earlier
described in details [27]. The present analyses included 2080 women and their singletons with
available cord 25OHD analyses and anthropometric measures of the child at three months, 18
months and three years of age. We excluded preterm infants (born before gestational week
37+0) and singletons with severe congenital malformations or severe chronic diseases affecting
growth (Fig 1).
Assessment of 25OHD
Blood samples from early and late pregnancy (mean gestational age (GA) 12 and 29 weeks,
respectively) and mixed arterial/venous blood from cord were analysed for serum 25OHD
concentration by liquid chromatography tandem mass spectrometry (LC-MS/MS) using a
Thermo Scientific TLX1 system attached to a Thermo Scientific Vantage TSQ. The limit of
quantification was 0.15 nmol/L for both 25OHD2 and 25OHD3, but only concentrations
above 6.5 nmol/L were considered. Vitamin D status was reported as the sum of 25OHD2 and
25OHD3 concentrations [25]. All serum samples were stored at -80˚C until analysis. The anal-
ysis was externally calibrated against National Institute of Standards and Technology, Standard
Reference Material 972 [28].
Leg length, body ratios and length/height
Birth length was extracted from hospital files. Data from OCC follow-up visits at age three
months, 18 months and three years were extracted for total length/height, cephalo-caudal
length (CCL) at 18 months and sitting height (SH) at three years. CCL and SH were subtracted
from total length/height to generate the SLL measure.
CCL and total length were measured once to the nearest mm in supine position using a
SECA 216 infantometer in children younger than two years of age. Height was measured once
in standing position using a SECA 213 stadiometer to the nearest mm in children from two
years. SH was calculated as the mean of three measurements to the nearest mm using a SECA
213 stadiometer with the child sitting on a standard sitting chair of known height.
Covariates
We obtained data on maternal height, pre-gestational weight and pre-gestational body mass
index (BMI) from the general practitioner’s files. Maternal age, smoking habits, parity and GA
Cord vitamin D and growth
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at delivery were retrieved from hospital files and infants were considered preterm when
GA<37+0 weeks. Maternal skin-tone (Fitzpatrick-scale, where type I/II or type V/VI), and
paternal height were extracted from self-reported questionnaire data obtained prior to the first
antenatal visit to the OCC. Ethnicity and maternal educational level was provided by the
Municipality and ethnicity was defined as western or non-western according to parental ori-
gin. Women were categorized as smokers if they reported smoking during early pregnancy
regardless of quantity. Time spent outdoors during pregnancy and vitamin D supplementation
during pregnancy was self-reported in a questionnaire at 28 weeks of gestation. Gestational
weight gain was self-reported in a questionnaire approximately three months after birth. At
child age 1½ year, duration of exclusive breastfeeding (weeks) and intake of infant formula
after eight weeks of age (yes/no) were reported. Infant diet at this time was registered as num-
ber of dairy/fish/meat servings of any kind consumed on a daily basis with no regard of the
type of product being ingested. Dietary intake of calcium and vitamin D intake were estimated
Fig 1. Flowchart of inclusion of 2010 participants from the Odense Child Cohort. Including healthy singletons
born at term. Abbreviations: 25OHD: 25-hydroxyvitamin D.
https://doi.org/10.1371/journal.pone.0198724.g001
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by multiplying the frequency of self-reported consumed food with standard portion sizes [29]
and information obtained from Danish food composition tables [30] The intake of supplemen-
tary vitamin D was calculated based on self-reported data on type and frequency of supple-
ments, and a database of all registered supplements in Denmark provided by the Danish
Veterinary and Food Administration [31]. Birth season was defined as winter (December-Feb-
ruary), spring (March-May), summer (June-August) and autumn (September-November) rep-
resenting seasonal fluctuations in 25OHD concentrations [25].
Statistical methods
We used visual inspection of QQ-plots to estimate data distributions, presenting mean and
standard deviation (SD) for normally distributed data and median and interquartile range
[IQR] for skewed data. When comparing the means of two groups, unpaired two-sided t-tests
were used for normally distributed data and Mann-Whitney for skewed data.
Age- and gender-adjusted Z-scores were generated for length/height and birth length for
term infants in monthly intervals using updated Danish reference curves by Tinggaard et al.
[32]. Values exceeding three SD from the reference mean were considered data entry errors
and were excluded from further analyses (n = 5).
Cord 25OHD was chosen as primary exposure and SLL at 1½ year as primary outcome.
Crude associations between continuous values of 25OHD and all outcomes were examined
using linear regression. The associations among boys (n = 281) and girls (n = 239) were evalu-
ated separately.
We modelled the adjusted associations between pregnancy and cord 25OHD and all
anthropometric outcomes using ordinary linear regression. Measures of 25OHD were used in
the model as either a continuous variable or as a categorical variable grouped by quartiles and
linear trends were examined using the Wald test. To control for confounding, the following
variables were included in all models: pre-gestational BMI, maternal ethnicity, smoking during
pregnancy, season of birth, and child age at examination. These covariates were selected
among all the variables defined in the section above through stepwise exclusion from the linear
model if they did not change the beta coefficient estimate by more than 10% in the primary
association between cord 25OHD and SLL at 1½ year. The variables in the above were chosen
in accordance with the current literature.
QQ-plots of residuals were used to evaluate model assumptions for linear regression mod-
els. No violations were found. Data analysis was performed using STATA 14.0 (StataCorp).
Significance level was defined as p<0.05 using two-sided tests.
Ethics
The study fulfilled the Helsinki II declaration. The Regional Committees on Health Research
Ethics for Southern Denmark (S-20090130) and the Danish Data Protection Board (case num-
ber 13/14088) approved the OCC and the present study. The parents of the participating chil-
dren gave written informed consent based on verbal and written information.
Results
Of the 2549 OCC participants, we included 2010 (79%) children who were born at term and
had available cord 25OHD samples and anthropometrics. Of these, 504 (21%) children (231
girls, 273 boys) had their SLL measured at the second follow-up visit at a mean (SD) age of
19.1 (0.9) months. SLL was measured in 956 children (39%; 455 girls, 501 boys) at the third fol-
low-up at a mean age of 36.3 (0.8) months. Post hoc power calculation indicated an 80%
Cord vitamin D and growth
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probability of detecting an association between cord 25OHD and SLL, if SLL changed a mini-
mum of 0.09 cm with every 10 nmol/Lchange in cord 25OHD.
Characteristics of the 2010 infant-mother pairs included are presented according to
25OHD quartiles, Table 1. The median cord 25OHD concentration was 45.2 [30.7–60.7]
nmol/L, with 17%< 25 nmol/L and 40% in the insufficient range 25–50 nmol/L. Compared to
children in the highest cord 25OHD quartile, children in the lowest quartile were more often
born during winter and spring and more likely had mothers of non-western ethnicity, mothers
with pre-gestational BMI above 25 kg/m2, mothers with parity above three children, mothers
who took less than the recommended vitamin D supplement of 10 μg/day, or mothers who
smoked during pregnancy, Table 1.
The mean (SD) length/height was 52.0 (2.3) cm at birth, 63.2 (2.8) cm at three months; 84.0
(3.0) cm at 19 months, and 96.8 (3.6) cm at three years, S1 Table.
At 19 months, the mean SLL was 32.0 (1.48) cm for boys, 31.3 (1.78) for girls; CCL:L-ratio
0.62 (0.01) for each of the both sexes. At three years, SLL was 43.1 (1.98) cm for boys, 42.8
(2.00) cm for girls and SH:H-ratio was 0.56 (0.01) for boys, 0.55 (0.01) for girls. No children
were diagnosed with rickets in the study period.
Long bone length and cord 25OHD
We observed no crude associations between continuous values of cord 25OHD and our pri-
mary outcome, SLL at 19 months, Fig 2 and S2 Table (girls p = 0.8, boys p = 0.2). To our sur-
prise however, SLL for boys at three years was inversely related to cord 25OHD (p = 0.03).
No such crude association was seen in girls (p = 0.5). No crude associations were observed
between cord 25OHD and total length at 3-months-old boys, 19 months or three years of age.
In the adjusted linear model, cord 25OHD was inversely associated with SLL in19 months-
old boys, SLL decreasing 0.1 cm for each 10 nmol/L increase in cord 25OHD, p = 0.001,
Table 2. Moreover, SLL was 0.8 cm shorter for boys with cord 25OHD levels >60.7 nmol/L
(Q4) compared with boys with levels <30.7 nmol/L (Q1), with a dose-response relationship
across cord 25OHD quartiles (linear trend p = 0.004), Table 2, In line with these observations,
the CCL:L-ratio in 19-months-old boys was 0.0008 higher for every 10 nmol/L increase in
cord 25OHD (p = 0.04) and boys with cord 25OHD in Q4 had a 0.006 higher CCL:L ratio
compared to boys with levels in Q1 (linear trend, p = 0.01), Table 3.
In boys aged three years, SLL was also related to cord 25OHD, decreasing 0.1 cm for every
10 nmol/L increase in cord 25OHD, (p = 0.02), Table 2. In addition, SLL decreased with
increasing cord 25OHD quartiles (linear trend, p = 0.03). A similar observation was made in
SH:H increasing across quartiles of cord 25OHD (linear trend, p = 0.04), Table 3. There were
no associations found between SLL, CCL:L- or SH:H-ratio and cord 25OHD in girls regardless
of age, Tables 2 and 3. Post hoc analysis found no interactions between child sex and cord
25OHD at 19 months or three years (p = 0.2 and 0.3, respectively).
Cord 25OHD and total length/height
Length at birth and at three months, 19 months and three years of age and their Z-scores were
not associated with cord 25OHD in either boys or girls, S3 Table.
Maternal pregnancy 25OHD levels and anthropometrics
Early pregnancy 25OHD concentrations were not associated with SLL or CCL:L-ratio at 19
months, nor to leg length or SH:H-ratio at three years in either girls or boys, Table 4 and Fig 3.
In contrast, late pregnancy 25OHD was associated with SLL in 19-months-old boys with a
decrease by 0.1 cm with every 10 nmol/L increase in 25OHD in adjusted analysis. The CCL:L-
Cord vitamin D and growth
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Table 1. Basic characteristics of the 2010 participants.
N Quartiles of cord 25OHD, nmol/L p-value
< 30.7 30.8–45.1 45.2–60.6 > 60.7
Maternal characteristics
Maternal height, cm 2010 168.3 ± 6.51 168.0 ± 6.6 168.2 ± 6.1 168.5 ± 6.1 0.7
Maternal pre-gestational weight, kg 2010 69 [60–80] 2 66 [60–74] 66 [59–75] 65 [59–73] <0.001
Pregestational BMI, kg/m2 2010 24.3 [21.8–28.1] 23.3 [21.4–26.0] 23.5 [21.1–26.2] 22.8 [21.0–25.6] <0.001
Gestational weight gain, kg 873 15.1 ± 6.3 15.0 ± 5.6 15.5 ± 5.6 14.5 ± 5.2 0.4
Maternal age, y 2010 29.8 ± 4.6 30.4 ± 4.3 30.3 ± 4.3 30.0 ± 4.6 0.1
Smoking in pregnancy, n (%) <0.001
Smoker 98 43 (8.6) 18 (3.6) 19 (3.8) 18 (3.6)
Non-smoker 1912 460 (91.4) 484 (96.4) 484 (96.2) 484 (96.4)
Maternal educational level, n (%) 0.2
Lower 252 74 (19.5) 64 (16.3) 54 (13.7) 60 (17.7)
Intermediate 908 218 (57.5) 230 (58.7) 245 (62.2) 215 (63.2)
Higher 345 87 (23.0) 98 (25.0) 95 (24.1) 65 (19.1)
Ethnicity, n (%) <0.001
Western 1918 459 (93.2) 482 (95.8) 486 (98.6) 491 (97.1)
Non-western 92 44 (6.8) 20 (4.2) 17 (1.4) 11 (2.9)
Skin-type, n (%) 0.2
I/II White 299 86 (22.6) 84 (21.3) 66 (16.7) 63 (18.4)
III Darker white 889 207 (54.3) 239 (60.5) 249 (62.8) 194 (56.7)
IV Brown 309 82 (21.5) 67 (16.9) 78 (19.7) 82 (23.9)
V/VI Dark brown 17 6 (1.6) 5 (1.3) 3 (0.6) 3 (1.0)
Parity, n (%) <0.001
First child 1109 230 (45.7) 282 (56.2) 295 (58.7) 302 (60.2)
Second child 679 204 (40.6) 164 (32.7) 156 (31.0) 155 (30.9)
Third child or more 222 69 (13.7) 56 (11.1) 52 (10.3) 45 (8.9)
Time spent outdoors, mother, n (%) 0.002
Never/rarely 31 11 (2.9) 7 (1.8) 7 (1.8) 6 (1.8)
Sometimes 295 95 (24.9) 84 (21.2) 62 (15.7) 54 (15.8)
Often 920 204 (54.4) 252 (63.6) 256 (64.7) 208 (60.8)
Most of the time 270 72 (18.8) 53 (13.4) 71 (17.8) 74 (21.6)
Vitamin D supplementation in pregnancy, mother, n (%) <0.001
10 μg/day 157 64 (23.4) 33 (10.7) 36 (11.4) 24 (8.5)
>10 μg/day 1023 210 (76.6) 275 (89.3) 281 (88.6) 257 (91.5)
Paternal characteristics
Paternal height, cm 1223 182.6 ± 6.7 182.5 ± 7.0 183.2± 6.6 182.3± 6.7 0.3
Child characteristics
Gestational age (GA) at birth, w 2010 40 [39–41] 40 [39–41] 40 [39–41] 40 [39–41] 0.6
Season of birth n (%) <0.001
Winter (Dec-Feb) 489 190 (37.7) 143 (28.5) 107 (21.3) 49 (9.8)
Spring (Mar-May) 496 158 (31.4) 144 (28.7) 106 (21.1) 88 (17.5)
Summer (Jun-Aug) 477 29 (5.8) 78 (15.5) 135 (26.8) 235 (46.8)
Autumn (Sep-Nov) 548 126 (25.1) 137 (27.3) 155 (30.8) 130 (25.9)
Child sex, n (%) 0.6
Girls 948 241 (47.9) 228 (45.4) 247 (49.1) 232 (46.2)
Boys 1062 262 (52.1) 274 (54.6) 256 (50.9) 270 (53.8)
Child age at 18 months examination, m 1350 18.7 [18.3–19.4] 18.8 [18.2–19.4] 18.0 [18.4–19.6] 19.0 [18.4–19.5] 0.03
(Continued)
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ratio increased accordingly with 0.001 in boys with every 10 nmol/L increase in late pregnancy
25OHD, Table 4. In 3-year old boys SLL decreased 0.,09 cm and SH:H increased 0.0006 with
every 10 nmol/L increase in 25OHD. Late pregnancy 25OHD concentrations did not correlate
with leg length or SH:H-ratio in girls at any age, Table 4. No post hoc interaction terms reached
statistical significance. No consistent associations were found between early or late pregnancy
25OHD levels and total length/height Z-scores at any age in neither boys nor girls, S4 Table.
Discussion
In our prospective population-based Danish cohort of healthy children, leg shortening was not
observed with lower values of pregnancy or cord 25OHD. In contrast, a novel, significant asso-
ciation was identified between higher late pregnancy and cord 25OHD values and shorter SLL
and larger CCL:L ratios in 19-months- and 3-years-old boys, but not in girls.
Covariates
Cord 25OHD was related with season of birth, maternal ethnicity, pre-gestational BMI, parity,
maternal vitamin D supplementation and smoking in pregnancy, which is consistent with the
literature [33–35]. Cord 25OHD was not associated with duration of exclusive breastfeeding
or intake of infant formula after eight weeks of age and infant diet did not appear to confound
the association between cord 25OHD and SLL at 19 months. Breastfed infants may be at a
higher risk of rickets [36], but this did not apply to our cohort with a general high vitamin D
status. In keeping with our results, longitudinal growth trajectories at age seven months were
similar in breast vs. formula fed infants in an American cohort studying maternal vitamin D
supplementation during lactation [37].
Sub-ischial leg length
In a large Dutch birth cohort, comparable to the OCC e.g. regarding maternal educational
level and latitude, van Eijsden et al. [22] found no association between early pregnancy mater-
nal 25OHD concentration and height, leg length or relative leg length in 1208 children aged
5–6 years. This was in keeping with our findings, supporting that early pregnancy vitamin D
Table 1. (Continued)
N Quartiles of cord 25OHD, nmol/L p-value
< 30.7 30.8–45.1 45.2–60.6 > 60.7
Duration of exclusive breastfeeding, w 1230 18 [6–34] 19 [11–24] 20 [10–24] 20 [12–24] 0.06
Intake of infant formula after 8 weeks of age 0.06
Yes 92 19 (6.5) 21 (6.2) 34 (10.3) 18 (5.2)
No 1219 275 (93.5) 319 (93.8) 297 (89.7) 328 (94.8)
Dietary intake of calcium, mg/day 1243 489 [213–756] 495 [230–751] 495 [224–757] 489 [211–747] 0.06
Dietary intake of vitamin D, μg/day 1185 1.14 ± 1.01 1.18 ± 1.66 1.04 ± 0.90 0.98 ± 1.0 0.2
Vitamin D supplementation, μg/day 943 3.47 ± 2.21 3.98 ± 1.36 3.88 ± 1.45 4.03 ± 1.59 0.002
ANOVA was used for comparing means of numerical, normally distributed variables. Kruskall-Wallis was used for comparing medians of numerical variables not
normally distributed. Chi squared was used for comparing distributions of categorical variables. Abbreviations: 25OHD: 25-hydroxyvitamin D.
1 Median [IQR] (all such numbers).
2 Mean ± SD (all such numbers).
p-value for difference between lowest and upper cord 25OHD quartile.
Skin-type (I-IV) refers to Fitzpatrick scale.
https://doi.org/10.1371/journal.pone.0198724.t001
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status does not affect offspring linear growth. Our associations, linking SLL only to late preg-
nancy and cord 25OHD, diminished with longer time between exposure and outcome indicat-
ing that other postnatal factors may have diluted any possible effect of early life 25OHD on
SLL. Van Eijsden et al. did not present analyses split by sex, but inverse associations between
early pregnancy 25OHD and longitudinal growth in boys aged 5–6 years is probably not
expected to be detectable.
Fig 2. Scatterplot of the crude association between cord 25OHD and SLL at 19 months and three years by child sex. Sub-ischial leg
lengths (SLL) in cm for cord 25-hydroxyvitamin D (25OHD) in nmol/L fitted with a linear model. No significant, crude associations were
observed between cord 25OHD and SLL in either sex. Abbreviations: SLL: sub-ischial leg length. 25OHD: 25-hydroxyvitamin D.
https://doi.org/10.1371/journal.pone.0198724.g002
Cord vitamin D and growth
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As nutritional rickets is associated with short stature and reduced leg length, observing an
inverse association between cord 25OHD and SLL was highly unexpected, although our popu-
lation had no children with rickets and was generally healthy. We were unable to detect any
direct association with SLL in the lowest 25OHD range, possibly because very low 25OHD lev-
els were rare. Our population was therefore not suited to elucidate a potential reverse U-
shaped or J-shaped association between cord 25OHD and SLL in boys.
Table 2. Adjusted associations between cord S-25-hydroxyvitamin D and leg length at 19 months and three years for girls and boys. The linear regression was
adjusted for maternal pre-gestational BMI, smoking in pregnancy, maternal ethnicity, season of birth and exact child age at examination. Stratified by sex a priori.
Girls Boys
N β (95% CI) p N β (95% CI) p
SLL, 19 months
25OHD 231 -0.003 (-0.02;0.01) 0.6 273 -0.01 (-0.02;-0.003) 0.009
25OHD quartiles
ref: Q1
Q2 52 -0.20 (-0.93;0.53) 0.6 67 -0.30 (-0.83;0.23) 0.2
Q3 71 -0.13 (-0.82;0.57) 0.7 76 -0.46 (-1.00;-0.07) 0.04
Q4 65 -0.33 (-1.06;0.40) 0.4 72 -0.82 (-1.38;-0.26) 0.004
SLL, 3 years
25OHD 455 -0.004 (-0.01;0.01) 0.4 501 -0.01 (-0.02;-0.002) 0.01
25OHD quartiles
ref: Q1
Q2 115 -0.22 (-0.77;0.32) 0.4 121 -0.54 (-1.02;-0.06) 0.03
Q3 124 -0.38 (-0.89;1.17) 0.2 123 -0.37 (-0.86;0.13) 0.15
Q4 117 -0.19 (-0.77;0.40) 0.5 129 -0.67 (-1.19;-0.15) 0.01
Abbreviations: 25OHD: cord S-25-hydroxyvitamin D. Q1-Q4: study specific quartiles of cord S-25-hydroxyvitamin D. SLL: sub-ischial leg length.
https://doi.org/10.1371/journal.pone.0198724.t002
Table 3. Cord S-25-hydroxyvitamin D’s association with cephalo-caudal length:length ratio at 19 months and sitting height:height ratio at three years. The regres-
sion was adjusted for maternal pre-gestational BMI, smoking in pregnancy, maternal ethnicity, season of birth and exact child age at examination. Stratified by sex a priori.
Girls Boys
N β (95% CI) p N β (95% CI) p
CCL:L, 19 months
25OHD 231 -1e-05 (-1e-04;9e-05) 0.8 273 8e-05 (4e-06;1e-04) 0.04
25OHD quartiles
ref: Q1
Q2 52 -0.001 (-0.007;0.005) 0.7 67 0.002 (-0.002;0.006) 0.4
Q3 71 -0.001 (-0.007;0.005) 0.7 76 0.003 (-0.002;0.007) 0.3
Q4 65 -3e-04 (-0.006;0.006) 0.9 72 0.006 (0.001;0.01) 0.01
SH:H, 3 years
25OHD 455 -2e-06 (-5e-05;5e-05) 0.9 501 3e-05 (-2e-05;7e-05) 0.2
25OHD quartiles
ref: Q1
Q2 115 0.002 (-0.003;0.003) 0.9 121 0.002 (-3e-04;0.005) 0.09
Q3 124 -1e-04 (-0.003;0.003) 0.9 123 0.002 (-4e-04;0.005) 0.09
Q4 117 -4e-04 (-0.003;0.002) 0.8 129 0.003 (3e-04;0.006) 0.03
Abbreviations: 25OHD: cord S-25-hydroxyvitamin D. Q1-Q4: study specific quartiles of cord S-25-hydroxyvitamin D. CCL:L-ratio: cephalo-caudal length to total length
ratio. SH:H-ratio: Sitting height to total height ratio. 1e-06: 0.000001 (all such numbers).
https://doi.org/10.1371/journal.pone.0198724.t003
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Our dose-dependent inverse association between pregnancy and cord 25OHD and SLL at
both 19 months and three years was small and hence of little clinical relevance, yet statistically
significant. An underlying mechanism for causal relation remains unexplained including any
theory as to why the dose-dependent pattern was only observed in males. Foetal and infant
growth is a multifactorial process with major components of genetics, nutrition, and hor-
mones, especially the insulin growth factors (IGFs) and insulin [38]. As s-IGF-I, promoting
growth by proliferation of the growth plate, is inhibited by active vitamin D as demonstrated
in animal and in vitro studies [39–43], we speculate if higher vitamin D levels may restrict
infant linear growth through inhibition of IGF-I, which has higher serum concentrations in
boys than in girls. Alternative explanations may be searched in the expression of genes encod-
ing for the inactive C3-epimer vitamin D, VDR, vitamin D binding protein, etc. [44].
Total length and height
We found no consistent associations between pregnancy or cord 25OHD and total length or
height from birth to three years in either sex. Our results are supported by findings of van Eijs-
den et al. [22] in a Dutch cohort. Also Ong et al. [45] observed no association between mater-
nal 25OHD sampled at 26–28 weeks gestation and offspring length Z-scores at 18 months in
596 children of mixed ethnicity from Singapore with a lower rate of vitamin D insufficiency
(25%) and deficiency (6%) compared to our mothers (40% insufficient and 17% deficient). In
contrast, Eckhardt et al. [21] observed smaller length for age Z-scores in children whose moth-
ers had pregnancy 25OHD levels (26 weeks’ gestation) < 30 nmol/L with consistent results
across the first year of life. The smaller length for age Z-scores in Eckhardt’s <30 nmol/L
group may have been undetectable in our sample as we had only twelve late pregnancy
Table 4. Adjusted associations between S-25-hydroxyvitamin D measured in early pregnancy (<20 weeks gestation), in late pregnancy (>20 weeks gestation) and in
cord serum and leg length at 19 months and three years of age and cephalo-caudal length:length ratio at 19 months of age and sitting height:height ratio at three
years of age. The regression models were adjusted for maternal pre-gestational BMI, smoking in pregnancy, maternal ethnicity, season of birth and exact child age at
examination. Stratified by sex a priori.
Girls Boys
N β (95% CI) p N β (95% CI) p
SLL, 19 months
Early pregnancy 25OHD 143 0.002(-0.01;0.02) 0.8 173 -6e-04(-0.01;0.01) 0.9
Late pregnancy 25OHD 151 -5e-05(-0.01;0.01) 0.9 167 -0.02(-0.02;-0.007) 0.001
Cord 25OHD 231 -0.003 (-0.02;0.009) 0.5 273 -0.02 (-0.02;-0.003) 0.009
SLL, 3 years
Early pregnancy 25OHD 269 -0.01(-0.02;2e-05) 0.06 307 -3e-4(-0.009;0.01) 0.9
Late pregnancy 25OHD 321 -0.008(-0.01;1e-04) 0.06 342 -0.009 (-0.02;-0.002) 0.04
Cord 25OHD 455 -0.004 (-0.01;0.006) 0.4 501 -0.01 (-0.02;-0.002) 0.01
CCL:L-ratio, 19 months
Early pregnancy 25OHD 143 -8e-05(-2e-04;6e-05) 0.2 173 -1e-05(-1e-04;9e-05) 0.8
Late pregnancy 25OHD 151 3e-06(-9e-05;9e-05) 0.9 167 1e-04(4e-05;2e-04) 0.002
Cord 25OHD 231 -1e-05(-1e-04;9e-05) 0.8 273 8e-05 (4e-06;1e-04) 0.04
SH:H-ratio, 3 years
Early pregnancy 25OHD 269 4e-05(-2e-5;1e-4) 0.2 307 -1e-05(-6e-05;4e-05) 0.7
Late pregnancy 25OHD 321 2e-05 (-2e-05;6e-05) 0.4 342 6e-05 (2e-06;1e-04) 0.01
Cord 25OHD 455 -7e-06 (-4e-05;6e-05) 0.8 501 4e-05 (-2e-06;9e-05) 0.06
Abbreviations: 25OHD: S-25-hydroxyvitamin D. CCL:L-ratio: cephalo-caudal length to total length ratio. SH:H-ratio: Sitting height to total height ratio. SLL: sub-ischial
leg length. 1e-6: 0.000001 (all such numbers).
https://doi.org/10.1371/journal.pone.0198724.t004
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Fig 3. Adjusted associations between S-25-hydroxyvitamin D at different time points and leg length at 19 months of age by child
sex. This is a coefficient plot of linear regression showing beta-coefficients and their 95% confidence interval. The three separate
regressions illustrated model the association between S-25-hydroxyvitamin D in early pregnancy,<20 weeks gestation (triangles), in late
pregnancy,>20 weeks gestation (hollow squares) and in cord serum (diamonds) and leg length of 19-months-old girls and boys. No
association between early pregnancy S-25-hydroxyvitamin D and leg length seen in either sex. Late pregnancy S-25-hydroxyvitamin D
shows dose-response-like quality in the relationship to leg length in boys although only Q4 reaches significance, no such pattern in girls.
In boys, cord S-25-hydroxyvitamin D also shows dose-response relationship to leg length, Q3 and Q4 reaching significance, but no such
pattern in girls. Abbreviations: 25OHD: S-25-hydroxyvitamin D. w: weeks. GA: gestational age.
https://doi.org/10.1371/journal.pone.0198724.g003
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25OHD observations below this cut-off. Taken together, pregnancy and cord 25OHD had no
clinically important associations with linear growth in our generally healthy population of
infants.
Strengths and limitations
Strengths of the present study include its large sample size, prospective design, low dropout
rate, longitudinal measurements of serum 25OHD2+3, by use of the gold standard LC-MS/MS
method, and the inclusion of both early pregnancy, late pregnancy and cord 25OHD for the
detection of time windows of effect. Post hoc power calculations further indicated that the
study had sufficient power to identify true differences in SLL. Nonetheless, our findings war-
rant replication in other child cohorts and follow up to older child ages.
Our study was limited by the observational design disallowing causal conclusions. While
our design favoured conclusions on the primary association (cord s-25OHD and SLL at 1½
years), chance findings could not be ruled out in the secondary associations due to multiple
testing. Furthermore, we cannot exclude the possibility of residual confounding caused by
unmeasured or poorly measured factors. Information bias may be expected using question-
naires; however potential misclassification was expected to be non-differential between parents
having children of each sex. Data were missing, especially in cephalo-caudal length at 19
months. Most of the missing values were, however, caused by a temporary non-inclusion of
cephalo-caudal length measurements for 12 months halfway through the three-year study
period, hence missing data is expected to be random. Our participants were comparable with
the local Danish background population, except for fewer participants of non-Danish origin,
fewer smokers during pregnancy and more with higher education [27].
Conclusion
In a healthy child population with very few having vitamin D deficiency, lower 25OHD did
not associate with reduced leg length. In contrast, we identified a novel but small, significant
association between increasing late pregnancy and cord 25OHD and shorter leg length in
19-months and 3-years-old-boys, but not in girls. Early 25OHD did not associate to total body
length. In conclusion, early life vitamin D status had no clinically important associations with
linear growth in a generally healthy population of infants.
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